Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer

By sjmartinez • July 14, 2024

Preston MA, Ebrahimi R, Hong A, Bobbili P, Desai R, Duh MS, Gandhi R, Hanson S, Dufour R, Morgans AK. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urol Oncol. 2024 Jul 12:S1078-1439(24)00499-X. doi: 10.1016/j.urolonc.2024.05.026. Epub ahead of print. PMID: 39003108.

Tags: Androgen deprivation therapy, Cardiology/Epi, cardiovascular risk, Continuous ADT, Endocrine or metabolic risk, Intermittent ADT, Nonmetastatic prostate cancer, Publications, Veterans Administration

Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings

Chandavimol M, Samankatiwat P, Limsuwan A, Ngernsritrakul T, Aboulhosn J. Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using[...]

The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial

Golub LS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari[...]

Recognizing Innovation in Academic Advancement

Agusala K, Pundi K, Thakkar A, Cho D, Peterson ED, Bhatt A, Avari Silva JN. Recognizing Innovation in Academic Advancement. JACC Adv. 2025 Apr 8;4(5):101704.[...]